• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
HealthCoronavirus

Trump admits he’s taking the same anti-malaria drug that the FDA warns against

By
Justin Sink
Justin Sink
,
Jordan Fabian
Jordan Fabian
, and
Bloomberg
Bloomberg
Down Arrow Button Icon
By
Justin Sink
Justin Sink
,
Jordan Fabian
Jordan Fabian
, and
Bloomberg
Bloomberg
Down Arrow Button Icon
May 19, 2020, 5:37 AM ET

President Donald Trump said he is taking hydroxychloroquine, the anti-malaria drug that he’s promoted as a treatment to combat coronavirus infection, despite government warnings that it can cause serious side effects.

Trump said Monday at the White House that he’s been taking the drug for about a week and half. Vice President Mike Pence’s press secretary, Katie Miller, tested positive for coronavirus on May 8. Trump was not seen in Pence’s company following the diagnosis until Monday, when the vice president joined him for a meeting with restaurateurs.

Trump is a self-admitted germophobe, telling reporters he was wary of shaking hands even before the coronavirus pandemic, and theatrically distancing himself from former patients during press events.

At the same time, he has avoided other steps recommended by public health experts to slow the spread of the virus, such as wearing a mask. The Centers for Disease Control and Prevention says that wearing a mask when social distancing is not possible could prevent people who have the virus but don’t know it from spreading it to others.

The president has dismissed suggestions that he put on a mask, saying he is tested frequently. He said Monday he receives a test “every couple of days” and added he has “shown always negative.”

There is scant evidence that hyroxychloroquine is effective against the coronavirus. The Food and Drug Administration on April 24 cautioned against the use of hydroxychloroquine or chloroquine for Covid-19, the illness caused by the coronavirus, outside of a hospital setting or clinical trial, citing a risk of heart rhythm problems.

“I want the people of this nation to feel good,” Trump said at the meeting, where he disclosed to reporters that he’s taking the drug. He also said he had taken azithromycin, an antibiotic commonly known as a z-pak, and that he is taking a zinc supplement.

“There is a very good chance this has an impact, especially early on,” he said. “I’m telling you, so far I seem O.K.”

Pence didn’t answer when reporters asked whether he, too, was taking the drug. The White House didn’t immediately respond to a question about whether Miller’s diagnosis prompted Trump to begin taking it.

On Monday night, the White House released a memorandum from Sean Conley, the physician to the president and a Navy commander. Conley said in the memo that after discussions with Trump “for and against the use of hydroxychloroquine, we concluded the potential benefit from treatment outweighed the relative risks.”

The memo, however, did not say whether the doctor had actually prescribed the drug, or if Trump is taking it. Conley did confirm that the president “receives regular Covid-19 testing, all negative to date.”

“I get a lot of positive calls about it”

The National Institutes of Health’s Covid-19 Treatment Guidelines say the malaria drug alone should be avoided at high doses or with azithromycin, outside of clinical trials, because of the same concerns. One of Trump’s top medical advisers, Anthony Fauci, the director of the National Institute of Allergy and Infectious Disease, has publicly discouraged use of the drug against the coronavirus.

Read More: Trump-Touted Malaria Drug Fails in Covid-19 Study

“Here’s my evidence: I get a lot of positive calls about it,” Trump said. He added that he had not started taking the drug at the recommendation of his doctor, but had instead asked the White House physician whether he could take it and was told he could.

Trump first began touting the drug in mid-March, creating a rush for supplies of the pills among hospitals, doctors and people who wanted to use it as a preventive. The surge created shortages for lupus and rheumatoid arthritis patients, who also use the medicine. In April, azithromycin also went into shortage, according to the FDA.

During the week of March 20, hydroxychloroquine prescriptions jumped to 298,660, more than double a week earlier, according to data compiled by Bloomberg Intelligence. Prescriptions have since plummeted back to nearly normal levels.

When used by healthy patients on its own, hydroxychloroquine has a relatively well-established profile and is considered low-risk.

In several trials of hospitalized, severely ill patients with Covid-19, it has been shown to raise heart risks and rates of death when combined with azithromycin. The medicine is known to interfere with the heart’s electrical signals in extremely rare cases, and can cause sudden death.

Alarm on Fox

The president’s announcement was met by alarm on Fox News, where anchor Neil Cavuto pointed to a Department of Veterans Affairs study showing it was linked to higher rates of death in hospitalized Covid-19 patients with pre-existing conditions and other studies showing it was ineffective.

“If you are in a risky population here, and you are taking this as a preventative treatment to ward off the virus, or in a worst-case scenario you are dealing with the virus, and you are in this vulnerable population, it will kill you,” Cavuto said on-air. “I cannot stress enough: this will kill you.”

Some of the network’s opinion hosts, in particular Laura Ingraham, have promoted use of the drug against the coronavirus. Ingraham has met with Trump at the White House to advocate for the malaria drug, according to the Washington Post.

Trump, who will be 74 next month, suffers from pre-existing conditions including high cholesterol and obesity, according to reports from his medical exams as president.

About the Authors
By Justin Sink
See full bioRight Arrow Button Icon
By Jordan Fabian
See full bioRight Arrow Button Icon
By Bloomberg
See full bioRight Arrow Button Icon

Latest in Health

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

Latest in Health

drinks
CommentaryFood and drink
We need a new way of thinking about drinking: Time to replace the ‘standard drink’ with advice people can actually use
By Justin KissingerMay 2, 2026
3 hours ago
Simple App Review (2026): Expert Tested and Reviewed
Healthmeal delivery
Simple App Review (2026): Expert Tested and Reviewed
By Emily PharesApril 30, 2026
2 days ago
Premium card perks are ‘designed to create a win-win-win for everyone’ but customers are paying with heavy annual fees and data
Personal FinancePersonal Finance Evergreen
Premium card perks are ‘designed to create a win-win-win for everyone’ but customers are paying with heavy annual fees and data
By Catherina GioinoApril 30, 2026
2 days ago
hoskins
Commentaryoffices
Gensler Co-Chair: Hot-desking was supposed to save money. It may be costing you your culture
By Diane HoskinsApril 30, 2026
2 days ago
raw milk
Politicsmilk
Risk of paralysis, bacteria, even death is no match for Americans’ thirst for raw milk
By Laura Ungar, Jonel Aleccia and The Associated PressApril 29, 2026
3 days ago
The Best Protein Shakes of 2026: Tasted and Approved by Nutrition Experts
HealthDietary Supplements
The Best Protein Shakes of 2026: Tasted and Approved by Nutrition Experts
By Christina SnyderApril 29, 2026
3 days ago

Most Popular

Scott Bessent on financial literacy: 'it drives me crazy' to see young men in blue-collar construction jobs playing the lottery
Personal Finance
Scott Bessent on financial literacy: 'it drives me crazy' to see young men in blue-collar construction jobs playing the lottery
By Fatima Hussein and The Associated PressMay 1, 2026
23 hours ago
China dominates the world's lithium supply. The U.S. just found 328 years' worth in its own backyard
North America
China dominates the world's lithium supply. The U.S. just found 328 years' worth in its own backyard
By Jake AngeloApril 30, 2026
2 days ago
The U.S. economy is booming — just not where 50 million Americans live
Commentary
The U.S. economy is booming — just not where 50 million Americans live
By Derek KilmerMay 1, 2026
1 day ago
Current price of oil as of May 1, 2026
Personal Finance
Current price of oil as of May 1, 2026
By Joseph HostetlerMay 1, 2026
24 hours ago
A Chick-fil-A worker got fired and then showed up behind the register to allegedly refund himself over $80,000 in mac and cheese
Law
A Chick-fil-A worker got fired and then showed up behind the register to allegedly refund himself over $80,000 in mac and cheese
By Catherina GioinoMay 1, 2026
19 hours ago
Apple cofounder Ronald Wayne—whose stake would be worth up to $400 billion had he not sold it in 1976—says that at 91, he has no regrets
Success
Apple cofounder Ronald Wayne—whose stake would be worth up to $400 billion had he not sold it in 1976—says that at 91, he has no regrets
By Preston ForeApril 27, 2026
5 days ago

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.